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The lysosome, discovered only two  decades  ago  (1),  has  been  the  subject  of an 
enormous  body of experimental  work  (2).  Until  recently  detailed  investigations  of 
lysosomal metabolism  have  generally  been  confined  to  nonhuman  organisms.  The 
observations that certain heritable  diseases  involve the storage within lysosomes of 
abnormal quantities  of characteristic  substances have been accompanied by signifi- 
cant advances in the understanding of normal and abnormal lysosonlal metabolism 
in  man.  A  number  of these  storage  disorders,  including Pompe's disease  (3),  Tay 
Sach's disease  (4),  Gaucher's  disease  (5),  metachromatic leukodystrophy  (6),  GM1 
gangliosidosis  (7),  Niemann-Pick disease  (8),  acid phosphatase  deficiency (9),  Wol- 
man's disease  (10),  Fabry's disease  (11), and fucosidosis  (12) have been attributed to 
decreased activity of specific lysosomal acid hydrolases.  Considerable information is 
now available about the enzymatic complement of human and animal lysosomes, and 
about the physiological importance of these enzymes (13). 
Some lysosomal enzymes degrade proteins to amino acids and small peptides,  but 
relatively little is known about the mechanism by which these small metabolites leave 
the lysosome. Certain cells appear capable of discharging their intralysosomat contents 
by exocytosis (14), but in many cells this process appears to be relatively inactive. A 
mechanism for penetration  of the lysosomal membrane by small metabolites  is pre- 
sumed to be operative. Because of the fragility of isolated lysosomes, the permeability 
phenomena  involving amino  acids  and  peptides  have  been  difficult  to  investigate 
directly. 
In 1969, Ehrenreich and Cohn described an imaginative approach for investigating 
these lysosomal properties in situ in mouse peritoneal macrophages (15). If the macro- 
phages were maintained  in culture and exposed to relatively high concentrations of 
certain indigestible D-peptides they developed a pronounced cytoplasmic vacuolation. 
The mechanism of vacuolation appears to be as follows: tested compounds are ingested 
into the lysosomes by cellular endocytosis; if the compound cannot be metabolized 
within  the lysosomes and cannot readily penetrate  the lysosomal membrane,  it ac- 
cumulates within these organelles which undergo osmotic swelling  and become visible 
as  lucent  vacuoles.  Using  this  technique  Ehrenreich  and  Cohn  found  that  mouse 
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macrophage lysosomes are relatively impermeable to peptides with molecular weights 
of greater than 220-230. 
We have found that the methods developed for the study of mouse macrophages 
can be adapted to permit investigation of human lysosomal metabolism in cultured 
skin fibroblasts. The responses of normal fibroblasts, and fibroblasts from individuals 
homozygous and  heterozygous for cystinosis,  a  rare  autosomally-inherited  disorder 
of cystine metabolism, have been investigated  after  exposure to a  variety of amino 
acids, peptides, and disulfide  compounds. 
Cystinosis is clinically manifested by the Fanconi syndrome and progressive glo- 
merular insufficiency  causing death in childhood (type  1)  (16,  17), although clinical 
variants with absence of renal disease  (type 2) (18, 19) or onset of renal manifestations 
after  childhood  (type 3)  (20,  footnote  1)  are  recognized. The  tissues  of cysfinotic 
individuals contain massive amounts of cystine, which appears to accumulate intra- 
cellularly. Electron micrographs have demonstrated crystalline (21-23)  or amorphous 
(24) inclusions within cystinotic lysosomes, and accretions of cystine in sonicates of 
cystinotic white cells  co-equilibrate with lysosomes after  isopycnic density gradient 
centrifugation (25). Although crystals assumed to be cystine have in a single instance 
been described in cystinotic mitochondria (26), the preponderance of evidence suggests 
that cystinosis is a lysosomal storage disease.  Cystinotic fibroblasts cultured in vitro 
have excessive amounts of stored cystine (nearly 100  X normal)  (27) and the cystine 
content  of fibroblasts  from heterozygous individuals  is  less  markedly  elevated  but 
usually greater than normal (27) ; hence the characteristic metabolic lesion in cystinosis 
is expressed  in the cultured fibroblasts, and the mechanism of cystine storage can be 
investigated using these cells. 
In the' studies reported here, the permeability characteristics of human fibro- 
blast lysosomes have been found to be remarkably  similar  to those  of mouse 
macrophage lysosomes. Cystinotic cells exhibited an abnormality in accumula- 
tion  of  disulfides  by  their  lysosomes.  The  experiments  suggest  that  normal 
lysosomes may have  a  mechanism  for lysosomal transport  or metabolism  of 
disulfides with cysteine moieties, and that a congenital deficiency of this mecha- 
nism may be the distinctive molecular lesion in cystinosis. 
Materials and Methods 
Chemlcals.--D-Alanine,  D-phenylalanine,  D-tryptophan,  D-L-allocystathionine,  and 
D-penicillamine (D-/3,/~-dimethylcysteine) were obtained  from Mann Research Labs,  Inc., 
New York; I)-carnosine from Cyclo Chemical Corp., Los Angeles, Calif.; D-valyl-alanine, 
D-alanyl-threonine,  D-trialanine,  and L-penicillamine from Fox Chemical Co., Los Angeles, 
Calif.; D-cysteine and L-cysteine from Sigma Chemical Co., St. Louis, Mo.; D-penicillamine 
disulfide and D-cystathionine from K  & K Laboratories Inc., Plainview, N. Y. 
The mixed disulfides of cysteine and penicillamine were prepared by the method of Craw- 
hall (28) using Amberlite resin 1R-120H (Fisher Scientific Co., Pittsburgh,  Pa.). L-Cysteine- 
D-penicillamine disulfide and  D-cysteine-L-penicillamine disulfide were recrystallized  from 
hot water or hot 25% ethanol, L-cysteine-L-penicillamine disulfide and D-cysteine-D-penicil- 
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lamine from  50-80%  ethanol. The L-L-  and  D-D-cysteine-penicillamine (mixed)  disulfides 
were less stable than the L-D or D-L mixed disulfides, and seemed to undergo some oxidative 
breakdown during air-drylng of their crystals.  L-Penicillamine disulfide was prepared by a 
slight modification of  the  procedure  used  for  the mixed  disulfides,  and  was  recrystallized 
from 80% ethanol. 
Tissue  Culture Methods.--Fibroblasts  were grown in glass bottles from primary skin ex- 
plants of cystinotic, heterozygous, and normal individuals by standard techniques in Eagle's 
medium #2  (National Institutes of Health Media Division) with 10% fetal calf serum  (In- 
dustrial Biological Labs.,  Rockville, Md.),  nonessential  amino  acids,  glutamine,  and  neo- 
mycin  (50 gg/ml)  in an atmosphere of 95% air-5% CO~ at 37°C.  Prior to exposure to a test 
compound the cells  were  detached with  0.25%  trypsin  in  Dulbecco's  phosphate  buffered 
saline, pH 7.4 (NIH Media Division), washed once in buffered saline without trypsin,  and 
plated  at  relatively low population densities into 35 mm plastic Petri dishes (Falcon Plastics, 
Los Angeles,  Calif.)  containing  12  mm glass cover slips (Arthur H. Thomas Co., Philadel- 
phia, Pa.)  and growth medium with 20% fetal calf serum. 
After the cells had been in subculture for 72 hr the medium was replaced with fresh medium 
containing 20% fetal calf serum and one of the test compounds at the indicated concentrations 
(usually 0.04 ~t). Media containing these compounds were adjusted to pH  7.4 with HC1  or 
NaOH,  if necessary,  and sterilized by Millipore filtration (Millipore Filter Corp.,  Bedford, 
Mass.) before use. After 20-24 hr of exposure to the test compounds the cells were fixed in 
glutaraidehyde (15). The cover slips were gently placed into cold 1.2% glutaraldehyde (purified 
by exposure to  activated charcoal)  in Sorensen's phosphate buffer, pH  7.4  (29).  After 5-7 
min the cover slips were rinsed with two changes of distilled water, and the ceils examined 
as unstained wet preparations using an inverted Nikon MS (Nikon Inc., Instrument Division, 
Garden City, N. Y.) phase microscope. Viewing was usually at 400 X  and photographs were 
obtained with a Polaroid attachment. 
Control cells,  treated  in  identical fashion but  not exposed  to  the test compound,  were 
prepared for each cell line in each experiment and were compared with the cells exposed to 
that compound.  This was  essential to  prevent false positive readings,  because certain cell 
lines occasionally showed vacuolation in the absence of exposure to any test compound; the 
reasons for vacuolation under these circumstances are unclear. 
Vacuolation was graded as positive or negative for the D-amino acids and peptides. To 
be called positive, nearly all the cells had to contain abundant and relatively large phase- 
lucent vacuoles after exposure to the test compound, and demonstrate negligible vacuolation 
in the absence of such exposure. For the tests with the disulfide compounds, the cultures are 
recorded in three categories: negative (unvacuolated), intermediate (up to 50% of cells with 
fine vacuoles), and positive (as described above) in order to classify more precisely the grada- 
tions of response to these substances. 
All tests were graded by one observer (J. D. S.); cells and test compounds were coded and 
the examiner had no knowledge of this code until completion of his scoring of the cells.  The 
effect of each test compound on each cell line was independently evaluated two to six times. 
In almost all cases these repetitive determinations were in agreement, and where this was not 
so is indicated in the tables. 
Quantitative Disulfide Analysis.--Cystinotic and normal cells were exposed in 32 oz pre- 
scription bottles to L-cysteine-D-penicillamine disulfide under the same conditions used to 
test for vacuolation. The cells were  then analyzed for intracellular disulfide levels by the 
method developed by Schneider for intracellutar cystine analysis (30), using a  Model  12013 
Beckman amino acid analyzer  (Beckman Instruments, Inc., Fullerton, Calif.)  modified for 
high sensitivity and employing the gradient elution system of Crawhall (31). 
Purity  of  the  various  disulfides used in the  vacuolation experiments was  confirmed by 
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RESULTS 
Induction of Vacuolaion in Cystinotic  and Normal Cells by D-Amino Acids 
and Peptides.--Table I  indicates the results of testing a  range of amino acids 
and peptides on several lines of cystinotic and normal cells. D-Tryptophan and 
D-cystathionine were toxic to all cell lines, and vacuolation could not be graded 
for  these  compounds.  D-L-Allocystathionine  and  D-carnosine  were  slightly 
toxic  at  the  higher  concentrations  (0.06-0.07  M)  but  this  degree  of  toxicity 
appeared not to interfere with observations on vacuolation. There is a striking 
correlation between molecular weight of the amino acids and nonbiodegradable 
peptides and their capacity to induce vacuolation.  D-Trialanine,  with  a  mo- 
TABLE  I 
Production  of Vacuolization  in Cystinotic  and  Normal Fibroblasts In  Vitro 
Molecular  Added compound 0.04-0.07 •  weight 
Vacuolization 
Cystlnotic  Normal 
D-Alanine  89  0  0 
D -Valine  117  0  0 
D -Phenylalanine  165  0  0 
D-Val-ala  188  0  0 
D-Ala-threo  192  0  0 
DL-Allocystathionine  222  4-  -4- 
D-Carnosine  226  ±  + 
D-Trialanine  231  Pos.  Pos. 
0 =  negative; 4- indicates variable scores in each group; Pos. =  positive. 
lecular weight of 230,  uniformly vacuolized all cell lines. The slightly smaller 
D-L-allocystathionine  and  D-carnosine  molecules vacuolized  both  cystinotic 
and normal cells, but the results"were somewhat variable in that certain cell 
lines  did  not  show  appreciable vacuolation  on  exposure to these  compounds 
(Figs. 1 and 2). 
The  results  indicate  that  in  both  cystinotic  and  normal  cells,  the  critical 
molecular weight  above which vacuolation occurs is 220-230.  Cystinotic and 
norma! lysosomes thus appear to have a similar permeability to a graded series 
of amino acids and peptides. Human fibroblasts behave in a remarkably similar 
manner to mouse peritoneal macrophages in this test system; in the mouse the 
critical molecular weight for vacuolation is also about 230 (15). 
Induction of Vacuolation in Cystinotic, tteterozygous, and Normal Cells by Ex- 
posure to Disulfides.--The molecular weight of cystine is 240,  larger than the 
220-230 which induces vacuolation. L-Cystine and D-cystine are too insoluble, 
however, to be tested for their capacity to vacuolize. The mixed disulfides of 
cysteine and penicillamine (mol wt 269)  are soluble enought to achieve 0.04 1094  METABOLISM  OF  AMINO  ACIDS,  I:EETIDES~  AND  DISULFIDES 
solutions  in  tissue  culture  medium;  the  penicillamine  disulfides  (tool  wt  298) 
are even more soluble.  These compounds were  therefore  tested  for capacity to 
induce  vacuolation  (Figs.  3-5)  in  normal  cell  lines,  cell  derived  from  children 
with the classic'~l, lethal form of cystinosis (type 1), and one cell line from each 
FIG.  1.  Normal fibroblasts.  Phase-lucent  vacuoles are not seen. Dense bodies are visible 
in the cytoplasm.  X  700. 
of the  rare variants  of cystinosis  (types  2  and  3).  L-Cysteine-D-penicillamine 
disulfide an  d L-penicillamine disulfide were each tested with the largest number 
of cell lines, including  five from individuals  heterozygous for type  1 cystinosis. 
D-Cysteine-D-penicillamine  disulfide was toxic to all cell lines, perhaps because 
of  an  unidentified  impurity  caused  by  oxidation  during  its  recrystallization, 
and  was not  further  studied.  (Reduced)  D-  or L-penicillamine  also was  toxic 
to all cells at 0.04 M concentrations. 
L-Cysteine-D-penicillamine  disulfide produced prominent vacuolation  of the 
nine  cell  lines  from  individuals  with  type  1  cystinosis  (Tables  II  and  III). JOSEPH  D.  SCHULMAN  AND  KATHRYN  H.  BRADLEY  1095 
Vacuolation of the cells from the two patients with the less severe variants of 
eystinosis was  usually less  striking;  although  most  of  the  cells in  these  two 
lines  manifested vacuolation  on  exposure  to  this  compound,  the  size  of  the 
vacuoles was  usually  smaller  than  those  observed in  cells from  the  classical 
form of the disease.  Cells from individuals heterozygous for type 1 cystinosis 
FIO.  2.  Normal fibroblasts exposed to D-trialanine.  X  800. 
did not demonstrate positive vacuolation; however, one of these five lines ex- 
hibited  intermediate  vacuolation  which  was  difficult  to  distinguish  from the 
appearance of the type 3  cystinotic cells.  All seven normal cell lines failed to 
vacuolize on exposure to this disulfide. 
The  same  general  results  were  obtained  with  the  less  extensively  studied 
L-cysteine-L-penicillamine disulfide  and  D-cysteine-L-penicillamine disulfide. 
Cystinotic  cells  gave positive,  or  in  certain  cases  mixed  positive  and  inter- 
mediate  responses,  on  replicate  scoring.  As  with  L-cysteine-D-peniciUamine 1096  METABOLISM  OF  AMINO  ACIDS,  PEPTIDES,  AND  DISULFIDES 
disulfide,  normal  cell  lines failed  to vacuolize on  exposure to either of these 
mixed disulfides. 
In striking contrast to the results with the mixed disulfides, D-penicillamine 
disulfide  or  L-penicillamine  disulfide  produced  prominent  vacuolation  in  all 
Fro. 3.  Cystinotic fibroblasts treated with L-cysteine-L-penicillamlne  disulfide. X 800. 
tested cell lines. There was no observable tendency toward selective vacuola- 
tion in cystinotic cells with either of these test compounds. 
Inlracellular  Disulfide  Levels after  Exposure  to  L-Cysteine-D-Penicillamine 
Disulfide.--Normal fibroblasts exposed to L-cysteine-D-penicillamine disulfide 
had an intracellular content of this disulfide of 3.20 #mole 1~ disulfide/gram 
cell protein. In marked contrast,  and in complete harmony with the vacuola- 
tion data previously described, the disulfide content of type  1 cystinotic cells 
was 67.8/zmole t/~ disulfide/gram cell protein, more than twenty times greater 
than in the normal cells. This strongly supports the suggestion that the mixed JOSEPH  D.  SCHULMAN AND  KATHRYN H.  BRADLEY  1097 
disulfide  accumulates  within cystinotic lysosomes to  a  much greater extent 
than within normal lysosomes. 
DISCUSSION 
The present observations  represent  in part a systematic investigation of the 
capacity of  normal human lysosomes to metabolize  amino  acids,  nonbiode- 
FIG. 4.  Cystinotic fibroblasts exposed to L-cysteine-D-penicillamine  disulfide.  )< 800. 
gradable peptides,  and certain low molecular weight disulfides. Human fibro- 
blasts in culture have been shown to be excellent subjects for such investiga- 
tions.  The  vacuolation method  developed  by Ehrenreich  and  Cohn,  when 
applied  to  the  investigation  of  human  lysosomal  metabolism,  indicates  a 
striking similarity in the permeability characteristics  of the lysosomes of the 
mouse peritoneal  macrophage  (15) and the human fibroblast. In both types of 
cells, the lysosomal membrane apparently constitutes a significant permeability 
barrier  for amino  acids  and peptides  with molecular  weights  of  220-230 or 1098  METABOLISM  OF  AMINO  ACIDS,  PEPTIDES,  AND  DISULFIDES 
greater. These observations on different cell types from two different organisms 
suggest  that  the  permeability  characteristics  of  lysosomes  in  mesodermally 
derived cells of many mammals may be quite similar,  and that the results of 
Fro. 5.  Cystinotic fibroblasts treated with D-cysteine-L-penicillamine  disulfide. M 800. 
experimental studies  of lysosomal permeability in mammals  may be directly 
applicable to man. 
These studies begin to clarify our understanding of the mechanism of cystine 
storage within eystinotic cells, and of the metabolism of disulfides by lysosomes. 
Despite evidence favoring the concept that cystine is stored within lysosomes 
in cystinosis (21-25), it has been difficult to understand how a  metabolite as 
small  as  cystine would  remain  compartmentalized within  the  lysosomal  en- 
velope. This phenomenon can now be better understood in  terms  of the  ex- TABLE  II 
Disulfide-Induced Vacuolation 
L-cyst.-  L-cyst.-  D-cyst.-  D-pen.  L-pen. 
Source  D-pen.  L-pen.  L-pen.  disulfide  disulfide 
Normal  J.z. 
R.M. 
R.T. 
A.B. 
j.w. 
J.M. 
B.H. 
Heterozygotes  M.B. 
F.K. 
X. McG. 
S.M. 
A.M. 
Cystinosis (Type 1) 
Cystinosis (Type 2)  D.P. 
Cystinosis (Type 3)  D.S. 
0  O*  O*  Pos.  Pos. 
0  0  O*  Pos.  Pos. 
0  0  0  --  Pos. 
0  0  0  --  Pos. 
0  0  0  --  Pos. 
0  0  0  Pos.  Pos. 
0  0  0  Pos.  Pos. 
Int.  --  --  --  Pos. 
0  --  --  --  Pos. 
0  --  --  --  Pos. 
0*  --  --  --  Pos. 
0  --  --  --  Pos. 
C.K.  Pos.  --  --  Pos.  -- 
J.G.  Pos.  Pos.  Int.*  Pos.  Pos. 
M.P.  Pos.  Int.*  Int.*  Pos.  Pos. 
S. McG.  Pos.  --  --  Pos.  Pos. 
S.I.  Pos.  Pos.  Pos.  Pos.  Pos. 
D.R.  Pos.  Pos.  Pos.  Pos.  Pos. 
T.M.  Pos.  --  --  Pos.  Pos. 
I.M.  Pos.  Pos.  Pos.  Pos.  Pos. 
W.R.  Pos.  --  --  --  Pos. 
Pos.*  Pos.  Int.*  Pos.  Pos. 
Int.  Int. *  Pos.  Pos.  Pos. 
* Variable ratings, the most common or lower rating is given  for  each  cell  line.  All  di- 
sulfide concentrations are 0.04 M. 0  =  negative; Int.  =  intermediate; Pos  =  positive. 
TABLE  nI 
Composite Scores, Disulfides 
L-cyst.-D-pen.  L-cyst.-L-pen.  D-cyst.-L-pen.  D-pen. disulfide  L-pen. disulfide 
Source  Pos., Int., Neg.  Pos., Int., Neg.  Pos., Int., Neg.  Pos., Int,, Neg.  Pos., Int., Neg. 
0  0  7  0  0  7  0  0  7  4  0  0  7  0  0 
0  1  4  5  0  0 
9  0  0  4  1  0  3  2  0  8  0  0  8  0  0 
Normal 
Heterozygotes 
Cystinosis, 
Type 1 
Cystinosis, 
Type 2 
Cystinosis, 
Type 3 
1  0  0  1  0  0  0  1  0  1  0  0  1  0  0 
0  1  0  0  1  0  1  0  0  1  0  0  1  0  0 
Pos.  =  positive; Int.  =  intermediate; Neg.  =  negative. 
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periments on the fibroblasts. Lysosomal membranes of the human fibroblast 
present a significant diffusional barrier to effiux of substances with molecular 
weights greater  than 220-230.  Cystine has  a  molecular weight  of  240  (the 
highest of any naturally-occurring amino acid),  and its trapping within cys- 
tinotic lysosomes appears to be explicable in terms of its molecular size. The 
molecule may be too large to penetrate the 4 A pores which are thought to be 
present  in  areas  of  micellar  organization  within  the  lysosomal membrane 
(15, 29). Furthermore, cystine is insoluble in nonpolar solvents and this could 
be an additional factor inhibiting its  diffusion through areas of the lysosomal 
membrane which might consist of continuous bimolecular leaflets (32);  both 
molecular weight and lipid-water partition coefficients seem to determine the 
rate of penetration of permeants through artificial model membranes (33). 
Normal  cells,  however,  do  not  demonstrate  lysosomal  accumulations  of 
cystine. It  appears  therefore  that  normal  human lysosomes may contain a 
transport system which facilitates the efflux of cystine from the lysosomes or 
an enzyme which converts cystine to a  smaller or more permeable molecule. 
In human cystinosis, one would expect that this mechanism preventing the 
accumulation of cystine within the lysosomes would be inoperative. 
The failure of induction of vacuolation in normal fibroblasts by cysteine- 
penicillamine disulfides which closely resemble cystine in molecular size, weight, 
and  structure  adds  strong support  to  this view. The mixed  disulfides have 
molecular weights of 269 and on the basis of size alone should be vacuolizing 
agents. That they do not vacuolize normal cells implies the presence of a phys- 
iological mechanism for their metabolism within, or transport from, the lyso- 
somes. 
Human cystinotic cells should be deficient in this activity, and the vacuola- 
tion of cystinotic cells by the mixed disulfides and their excessive accumulation 
of L-cysteine-D-penicillamine disulfide are entirely consonant with this view. 
The nature of the  specific  gene product  which appears  to be  deficient in 
cystinotic lysosomes requires further clarification. The experimental evidence 
presented here suggests that this gene product will be active with both L- and 
D-cystine,  since L-  and D-cysteine  disulfides do  not  induce vacuolation of 
normal cells. The data also suggest that it will be inactive toward D-penicilla- 
mine disulfide and L-penicillamine disulfide, since  these disulfides cause pro- 
nounced vacuolafion of both cystinotic and normM lysosomes. 
Any lysosomal mechanism for reducing  cystine to  the much  smaller  and 
presumably more permeable cysteine (mol wt 121) could account for lack of 
cystine accumulation in  normal  lysosomes. Little is  known  however  about 
disulfide reduction or other aspects of disulfde metabolism in lysosomes. Peake 
and associates noted that (reduced)  glutathione enhances proteolysis by thy- 
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do so is to undergo disulfide exchange reactions with the cystine bridges of the 
protein (34).  The physiological significance of this observation is unclear, and 
the  exchange  reactions with cystine could be nonenzymatic. There  is  some 
evidence that lysosomes of the rat intestinal epithelium contain a  cystine-re- 
ducing enzyme, cystine-glutathione transhydrogenase, which is also present in 
the soluble cell fraction (35). Our own investigations however provide little sup- 
port so far for the view that cystine-glutathione transhydrogenase plays a phys- 
iologically significant role in lysosomal disulfide metabolism in  cystinotic (30) 
or  normal  white  cells,  particularly at the acid pH presumed to exist within 
lysosomes and typical of the pH optimum of nearly all lysosomal enzymes (13, 
footnote 2). 
A transport system for cystine in the lysosomal membrane remains a signifi- 
cant theoretical possibility. Lucy has suggested that the processes involved in 
removing certain low molecular weight substances from lysosomes could in- 
volve the active transport of amino acids, sugars, and ions (33).  Although no 
such mechanisms have been defined, the low internal pH of lysosomes may well 
be maintained by an active transport system for hydrogen ions. Furthermore, 
ATP-ase activity, which may be associated with membrane transport systems, 
has been reported in lysosomal particles (36, 37). 
While the basic mechanism remains elusive, the studies of disulfide-induced 
vacuolation reported here provide  rather  strong confirmatory evidence that 
cystinosis is  a  lysosomal storage  disease  and provide  some insight into the 
properties  of the lysosome which plays a  role in such storage. Furthermore, 
the  selective  induction of  vacuolation in  cystinofic fibroblasts by  the  con- 
veniently synthesized L-cysteine-D-penicillamine disulfide provides  the  first 
histological marker for these genetically abnormal cells. This marker may prove 
useful in further investigations of cystinosis. Selective vacuolation might be 
applied toward the diagnosis of cystinosis using a very small number of cells, 
but the undefined variables which affect vacuolation in cultured cells indicate 
the need for extreme caution should this be attempted. We feel that the diag- 
nosis of cystinosis by the specific measurement of intracellular cysfine (28, 38) 
is, whenever feasible, greatly preferable to the vacuolation technique. 
The demonstration that the permeability of human lysosomes may be con- 
veniently investigated in  genetically normal  and  abnormal  skin fibroblasts, 
which are readily accessible  and easily cultured, may encourage investigation 
of hitherto unstudied aspects of lysosomal metabolism in a number of genetic 
diseases of man3 
2  Tietze, F., and J. D. Schulman.  In preparation. 
3 A preliminary report on limited aspects of this work has  recently been published. 
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SUMI~ARY 
The metabolism of amino  acids,  peptides,  and  disulfides has been investi- 
gates in  cultured  skin  fibroblasts from normal  individuals  and patients  with 
cystinosis. Human fibroblast lysosomes closely resemble the lysosomes of mouse 
peritoneal macrophages in having an apparent permeability barrier to amino 
acids and peptides with molecular weights of greater than 220-230.  Cystinotic 
and normal cells behave similarly in this regard. Normal cells do not undergo 
lysosomal  swelling  when  exposed  to  cysteine-penicillamine  disulfides,  while 
cysfinotic  cells  are  prominently vacuolized  under  these  conditions.  Normal 
lysosomes may have a  specific mechanism for the disposal of cystine, and de- 
ficient activity of this mechanism in cystinotic lysosomes could result in cys- 
tine  storage  therein.  The demonstration  that  human fibroblasts can be used 
conveniently to study lysosomal metabolism of small substrates may facilitate 
investigations  of these  aspects  of lysosomal function  in  a  variety of  genetic 
diseases of man. 
We thank Doctors L. Laster and J. E. Seegmiller  for facilitating these investigations. 
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